More Fields

Filters

Profiles which have:

Recent Changes

Profiles with recent changes to:
Sign up to Download

1-4 of 4 results

  • www.pardesbio.com
  • 1
  • 18
Our lead product candidate, PBI-0451, is an oral coronavirus Main protease (M pro) inhibitor being developed to treat and prevent COVID-19. The FDA has granted PBI-0451 Fast Track designation, and we are actively enrolling patients in a Phase 2..
Relevance: 16.06514
  • pharmapprove.com
  • 1
  • 1
  • 27
PharmApprove is part of the NDA Group. Our international team of professionals offer our clients unparalleled breadth and depth of experience and knowledge... PharmApprove is an integral part of NDA Group - an international consultancy excelling in..
Relevance: 12.906912
  • www.arvinas.com
  • 9
  • 2
  • 45
Arvinas is a clinical-stage biotechnology company leading the way in targeted protein degradation therapeutics... Arvinas is founded by Yale professor Craig Crews with the goal of turning PROTAC® protein degraders into patient therapies..
Relevance: 7.9757547
  • ndareg.com
  • 2
  • 2
  • 46
We are an independent, private, family-owned business solely focused on giving pharmaceutical companies objective, impartial advice on how to accelerate patient access to important medical therapies... NDA provides unmatched regulatory expertise,..
Relevance: 6.753068